We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Brown-Forman Class A
BF.A
$13.4B
| $2K | ﹤0.01% |
+32
| New | +$2.3K |
|
1627
BOK Financial
BOKF
$8.58B
| $2K | ﹤0.01% |
+22
| New | +$1.42K |
|
1628
Brixmor Property Group
BRX
$9.67B
| $2K | ﹤0.01% |
+98
| New | +$1.39K |
|
1629
Beyond Meat
BYND
$292M
| $2K | ﹤0.01% |
+14
| New | +$2.11K |
|
|
CADE
1630
DELISTED
Cadence Bank
CADE
| $2K | ﹤0.01% |
+66
| New | +$1.67K |
|
1631
Cathay General Bancorp
CATY
$4.22B
| $2K | ﹤0.01% |
+57
| New | +$1.55K |
|
1632
COPT Defense Properties
CDP
$4.3B
| $2K | ﹤0.01% |
+72
| New | +$1.82K |
|
1633
Chegg
CHGG
$110M
| $2K | ﹤0.01% |
+20
| New | +$1.59K |
|
1634
Copa Holdings
CPA
$5.76B
| $2K | ﹤0.01% |
+24
| New | +$1.6K |
|
1635
Cousins Properties
CUZ
$5.19B
| $2K | ﹤0.01% |
+55
| New | +$1.7K |
|
1636
Douglas Emmett
DEI
$1.98B
| $2K | ﹤0.01% |
+59
| New | +$1.68K |
|
1637
Dell
DELL
$262B
| $2K | ﹤0.01% |
+51
| New | +$1.78K |
|
1638
Dolby
DLB
$5.51B
| $2K | ﹤0.01% |
+23
| New | +$1.9K |
|
1639
Entegris
ENTG
$18.1B
| $2K | ﹤0.01% |
+22
| New | +$1.92K |
|
1640
Equitable Holdings
EQH
$13B
| $2K | ﹤0.01% |
+64
| New | +$1.5K |
|
1641
Elastic
ESTC
$6.84B
| $2K | ﹤0.01% |
+13
| New | +$1.6K |
|
1642
First Financial Bankshares
FFIN
$5.04B
| $2K | ﹤0.01% |
+53
| New | +$1.74K |
|
1643
Frontdoor
FTDR
$5.1B
| $2K | ﹤0.01% |
+39
| New | +$1.78K |
|
1644
Fulton Financial
FULT
$4.66B
| $2K | ﹤0.01% |
+134
| New | +$1.59K |
|
1645
Glacier Bancorp
GBCI
$6.42B
| $2K | ﹤0.01% |
+41
| New | +$1.66K |
|
1646
Greif
GEF
$4.92B
| $2K | ﹤0.01% |
+44
| New | +$1.99K |
|
1647
Highwoods Properties
HIW
$3.65B
| $2K | ﹤0.01% |
+50
| New | +$1.81K |
|
1648
Herbalife
HLF
$1.29B
| $2K | ﹤0.01% |
+38
| New | +$1.83K |
|
1649
Home BancShares
HOMB
$6.23B
| $2K | ﹤0.01% |
+94
| New | +$1.71K |
|
|
HPP
1650
Hudson Pacific Properties
HPP
$747M
| $2K | ﹤0.01% |
+10
| New | +$1.65K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.